Pharma Pricing & Access Innovation Conference 2025

Michael Schlander is invited as a speaker to the PPIC | Pharma Pricing & Access Innovation Conference in Basel / Switzerland from June 03-05, and he will present under the heading ´Early Strategic Decision Making in Drug Development: The Role of Health Economics for Market Access´ - exploring the strategic importance and benefits of early advise consultations for pharmaceutical manufacturers. His focus will be on the national HTA agencies G-BA (Germany), HAS (France) and NICE (England and Wales) with examples of global trends in HTA. Topics will include the choice of surrogate endpoints and targeted subpopulations for HTAs, and the optimal use of patient reported outcomes (PROs) data in the context of international HTA trends, including the relevance of socioeconomic burden.

More detailed information can be found here.